SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

Share Price is delayed by 15 minutes
Get Live Data
141.60    -24.20 (-14.60%)
Bid:
140.20
Ask:
144.80
Spread: 4.60 (3.281%)
Market Cap: £241.94m
MCB Live PriceLast checked at - London Stock Exchange

Intraday Mcbride Share Chart

Trading Update

8 Jan 2013 07:00

RNS Number : 0158V
McBride PLC
08 January 2013
Β 

ο»Ώ

8th January 2013

Β 

McBride PLC

Β 

Trading Update

Β 

McBride PLC, Europe's leading provider of Private Label Household and Personal Care products, provides its trading update for the six months ending 31 December 2012.

Β 

Revenue at constant currency has declined by 6% as expected, mainly as a consequence of the previously announced wind-down in contract manufacturing. Private Label revenue at constant currency has declined by 2%, as a consequence of the decision to exit certain low-margin non-core Private Label business, although revenue from our Core and Future Growth categories has grown by 2%. Whilst trading in our Core and Future growth categories has been encouraging overall, we have seen some weaker trading in December in our core Western European markets as a consequence of the continued challenging economic environment in this region.

Β 

The Board therefore expects Adjusted Operating Profit for the first half to be around 12% higher than the same period in the prior year.

Β 

Net debt at the period end will be around Β£80m.

Β 

Looking forward, an increase in product launches early in the second half is expected to lead to significant Private Label revenue growth. However, the full impact of this growth in the second half will be dependent to some extent on the exact timing of customer product launches and wider economic conditions.

Β 

Chris Bull, Chief Executive, commented:

Β 

"As we reported at the full year and again at our Q1 IMS in October, our financial performance this year will be second-half weighted reflecting a wind-down in contract manufacturing that is allowing us to grow our Private Label business. I am therefore pleased that we expect to report first half revenue growth at constant currency of 2% in our Core and Future Growth categories, as Private Label has continued to win market share from the branded competition. We have in place an exciting programme of product launches for the second half that will accelerate further our Private Label revenue growth."

Β 

The Group intends to announce its interim results for the six months ending 31 December 2012 on 7th February 2013.

Β 

For further information please contact:

Β 

McBride plc

Chris Bull, Chief Executive

020 7539 7852

Richard Armitage, Group Finance Director

020 7539 7851

FTI Consulting

Ed Bridges, Marc Cohen

020 7831 3113

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTBDLLBXFFFBBD
Date   Source Headline
12th Jun 20267:00 amRNSTrading and Acquisition Update
11th Jun 20261:44 pmRNSDirector/PDMR Shareholding
2nd Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSSecond tranche of share buyback programme
1st May 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSProposed Acquisition & Trading Conditions Update
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSDirector Appointment
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20266:28 pmRNSDirectorate change
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:05 amRNSInterim results for 6M ended 31 December 2025

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.